2.03
-0.03(-1.46%)
Currency In USD
| Previous Close | 2.06 |
| Open | 2.03 |
| Day High | 2.07 |
| Day Low | 2 |
| 52-Week High | 7.95 |
| 52-Week Low | 1.93 |
| Volume | 80,030 |
| Average Volume | 181,904 |
| Market Cap | 11.96M |
| PE | -1.15 |
| EPS | -1.77 |
| Moving Average 50 Days | 2.35 |
| Moving Average 200 Days | 3.21 |
| Change | -0.03 |
If you invested $1000 in Vivos Therapeutics, Inc. (VVOS) since IPO date, it would be worth $9.03 as of December 27, 2025 at a share price of $2.03. Whereas If you bought $1000 worth of Vivos Therapeutics, Inc. (VVOS) shares 3 years ago, it would be worth $184.55 as of December 27, 2025 at a share price of $2.03.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan
GlobeNewswire Inc.
Dec 16, 2025 1:45 PM GMT
Vivos Eyes High Growth Potential from Commercial Affiliation with Prominent Auburn Hills, Michigan Sleep Practice MISleep SolutionsLITTLETON, Colo., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVO
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST
GlobeNewswire Inc.
Dec 15, 2025 10:30 PM GMT
LITTLETON, Colo., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company specializing in the delivery of highly effective diagnostic procedures
Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call
GlobeNewswire Inc.
Nov 19, 2025 1:30 PM GMT
Call scheduled for today, Wednesday, November 19, 2025, at 5:00 pm ETLITTLETON, Colo., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and healthcare services company sp